Quality of induced pluripotent stem cells is dramatically enhanced by omitting what was thought to be the most crucial reprogramming factor
Scientists at the Max Planck Institute for Molecular Biomedicine in Münster showed that Oct4, a factor most commonly used for reprogramming, is detrimental for the quality of induced pluripotent stem cells (iPSCs). Omitting Oct4 from the reprogramming cocktail allowed for the generation of mouse iPSCs with the highest developmental potential reported to date (Cell Stem Cell, November 7, 2019, epub ahead of print).
The ultimate pluripotency test: after tetraploid complementation an adult All-iPSC mouse developed.
© MPI Münster / Sergiy Velychko
Embryonic stem cells (ESCs) that comprise the inner cell mass of an early mammalian embryo, called blastocyst, possess the unique power of pluripotency. These cells can divide indefinitely and retain their ability to differentiate into any tissue type or even give rise to a complete animal when transferred back into a blastocyst.
The technology of proliferation and differentiation of pluripotent cells in vitro holds tremendous potential both for understanding human development and for clinical applications, such as drug screening and regenerative cell therapies.
The derivation of human ESC lines and their usage for research, however, remain controversial. Germany has a rather strict Stem Cell Act, not only prohibiting the generation of human ESC lines but also any research involving ESCs derived after 2007 from otherwise discarded embryos in fertility clinics in other countries.
The iPSC technology pioneered by Shinya Yamanaka allows for reprogramming of adult cells, such as skin fibroblasts, back to an ESC-like state by forceful overexpression of four transcription factors: Oct4, Sox2, Klf4, and cMyc (OSKM). While posited by many as the ultimate replacement of ESCs, multiple studies showed that iPSCs do not quite match the ‘gold standard’ ESCs in their developmental potential.
The reprogramming process appears to be too crude, often leading to potentially cancerous aberrations such as loss of epigenetic silencing at specific loci in the genome inherited from one of the parents, known genomic imprinting. For the mouse model, this results in the failure of many of OSKM iPSC lines to support normal differentiation. The exact origin of or agent that causes these changes has never been determined.
A team headed by Hans Schöler were exploring the roles of different components of the Yamanka cocktail in reprogramming to pluripotency. Sergiy Velychko, PhD candidate who led the experiments, explains: “We created a new construct in which we removed Oct4 from the reprogramming vector to serve as a negative control. To my great surprise the control SKM-construct could generate iPSCs with high efficiency only slightly delayed, comparing to OSKM.”
Other studies that used a SKM-construct showed no reprogramming. “We later found that the discrepancy with previous studies could be explained by the retroviral vectors that Yamanaka, and many others, used in their experiments,” says Velychko. “Those retroviral vectors can silence themselves, halting the reprogramming process altogether.”
“Interestingly, we found that the iPSCs generated without Oct4 were more similar to ESCs, and, crucially, all of our SKM-lines preserved the correct imprinting pattern. Finally, when we tested SKM-iPSCs in the most stringent test for pluripotency – the ability to create all-iPSC mice through a technique called tetraploid complementation – we found that SKM-iPSCs could give rise to fully developed mice with an average 20 times higher competence than traditional iPSCs.”
Hans Schöler, who discovered the Oct4 gene back in 1989, says: “Our results show that after 13 years of iPSC technology, we still do not fully understand the consequences of this artificial process. We were stunned to realize that removing Oct4 from the reprograming cocktail was sufficient to equalize the developmental potential of mouse iPSCs to the level of ESCs.”
Although human reprogramming without Oct4 still has to be shown, Hans Schöler argues: “I do not see any reason why Oct4 should act differently in human cells than in mouse cells. And if Oct4 also messes around with imprinting in human cells as it does with mouse cells, then the reprogrammed cells bear the risk of causing cancer.”
And Schöler continues: “Moreover, as the current human iPSC-lines that were generated with Oct4 might not be fully pluripotent, we also in future will need human ESCs as the gold standard of pluripotency. This knowledge is especially important for countries such as Germany, where the research with human ESCs is restricted and human iPSCs have been argued to be able to replace human ESCs.”
Sergiy Velychko, Kenjiro Adachi, Kee-Pyo Kim, Yanlin Hou, Caitlin M. MacCarthy, Guangming Wu, Hans R. Schöler. Excluding Oct4 from Yamanaka cocktail unleashes the developmental potential of iPSCs. Cell Stem Cell, November 7, 2019 (epub ahead of print). DOI:10.1016/j.stem.2019.10.002
Dr. Jeanine Müller-Keuker | Max-Planck-Institut für molekulare Biomedizin
A new 'cool' blue
17.01.2020 | American Chemical Society
Neuromuscular organoid: It’s contracting!
17.01.2020 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft
Styrofoam or copper - both materials have very different properties with regard to their ability to conduct heat. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz and the University of Bayreuth have now jointly developed and characterized a novel, extremely thin and transparent material that has different thermal conduction properties depending on the direction. While it can conduct heat extremely well in one direction, it shows good thermal insulation in the other direction.
Thermal insulation and thermal conduction play a crucial role in our everyday lives - from computer processors, where it is important to dissipate heat as...
In order to advance the transfer of research developments from the field of quantum sensor technology into industrial applications, an application laboratory is being established at Fraunhofer IAF. This will enable interested companies and especially regional SMEs and start-ups to evaluate the innovation potential of quantum sensors for their specific requirements. Both the state of Baden-Württemberg and the Fraunhofer-Gesellschaft are supporting the four-year project with one million euros each.
The application laboratory is being set up as part of the Fraunhofer lighthouse project »QMag«, short for quantum magnetometry. In this project, researchers...
Microtubules, filamentous structures within the cell, are required for many important processes, including cell division and intracellular transport. A...
Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keep them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation saving many lives of patients with severe liver diseases or cancer.
Until now, livers could be stored safely outside the body for only a few hours. With the novel perfusion technology, livers - and even injured livers - can now...
A balloon-borne scientific instrument designed to study the origin of cosmic rays is taking its second turn high above the continent of Antarctica three and a half weeks after its launch.
SuperTIGER (Super Trans-Iron Galactic Element Recorder) is designed to measure the rare, heavy elements in cosmic rays that hold clues about their origins...
16.01.2020 | Event News
15.01.2020 | Event News
07.01.2020 | Event News
17.01.2020 | Life Sciences
17.01.2020 | Power and Electrical Engineering
17.01.2020 | Life Sciences